Accession Number : AD1064689

Title :   Cannabidivarin (CBDV) Versus Placebo in Children with Autism Spectrum Disorder (ASD)

Descriptive Note : Technical Report,01 Aug 2017,31 Jul 2018

Corporate Author : Albert Eintsein College of Medicine, Inc. Bronx United States

Personal Author(s) : Hollander, Eric

Full Text :

Report Date : 01 Aug 2018

Pagination or Media Count : 42

Abstract : The CDC currently estimates 1 in 59 children have Autism Spectrum Disorder (ASD). Children with ASD have problems with social communication, irritability, repetitive behaviors, impulsivity, temper tantrums, and a high caregiver burden. The only medications approved by the FDA for symptoms of ASD are aripiprazole and risperidone. Both of these are used to reduce irritability but have short-term and long-term side effects.

Descriptors :   autism , neurodevelopmental disorders , biomedical research

Subject Categories : Medicine and Medical Research

Distribution Statement : APPROVED FOR PUBLIC RELEASE